Accounts Receivable Outsourcing Services for Infectious Disease Practices in 2026

Receivables outsourcing is the use of an external resource or specialized partner to support accounts receivable activities such as claim follow-up, payment review, denial management, reconciliation, and reporting. For infectious disease practices, this may include complex evaluation, infusion, drug, hospital consult, OPAT, and specialty-drug claims. The purpose is to improve visibility into unresolved balances and identify why revenue is delayed, reduced, or left uncollected.

Support may include aging A/R review, payer follow-up, denial categorization, appeals, payment reconciliation, underpayment review, claim status work, reporting, and identification of revenue leakage. Infectious disease practices may also need attention to infusion administration, drug claims, authorization, medical-versus-pharmacy benefit issues, consult documentation, and payer contracts. The precise scope can be aligned with the practice’s existing team and systems.

Infectious disease revenue can come from cognitive visits, hospital consultations, infusion services, OPAT, drug billing, and contracted work. These streams may involve different documentation, authorization, coding, coverage, and reimbursement considerations. A/R work therefore requires more than generic claim follow-up; it benefits from understanding how clinical service lines, drug acquisition, payer rules, and contract terms affect the balance remaining on each claim.

Yes. Specialized denial support can categorize the underlying issue, such as missing authorization, coding concerns, medical-versus-pharmacy benefit confusion, unit or NDC mismatches, or insufficient documentation. The work may include payer-specific appeals supported by clinical records and feedback to clinical, coding, and front-office teams. Addressing the root cause can help reduce repeated denials rather than treating each claim as an isolated problem.

Underpayment review compares actual payment activity with expected reimbursement based on the applicable payer terms, service details, and claim information. For infectious disease practices, review may include drug, administration, evaluation, and consult claims. Potential issues can include short-pays, incorrect fee schedule application, unit mismatches, NDC discrepancies, or contract noncompliance. Findings can then be tracked for dispute, recovery, and future contract discussions.

Yes. Aging A/R work focuses on unresolved claims and balances, organized by payer, service type, and balance. Infectious disease practices may prioritize high-value drug and infusion claims, hospital consult claims, and complex outpatient visits. Effective follow-up documents claim activity, identifies where the process stalled, and reports recurring patterns so the practice can address both individual balances and broader workflow weaknesses.

Not necessarily. Outsourcing can provide full claims management, targeted A/R recovery, specialized denial and underpayment review, or overflow support for an internal team. The appropriate arrangement depends on the practice’s existing workflow, systems, staffing, service lines, and operational priorities. External support can be structured to complement clinical, coding, front-office, and administrative staff rather than removing their role.

A practice can examine reporting by payer, provider, service line, claim status, denial cause, payment trend, and aging balance. It should also connect financial findings to documentation, charge capture, coding, authorization, drug billing, and payer contract requirements. Using the practice’s own figures is important because generalized rates and margins may not reflect its contracts, services, costs, or operating model.